Wed, March 2, 2016
Tue, March 1, 2016
Mon, February 29, 2016
Fri, February 26, 2016
Thu, February 25, 2016
Wed, February 24, 2016
Tue, February 23, 2016

Kennen MacKay Maintained (BMRN) at Buy with Decreased Target to $125 on, Feb 26th, 2016

Kennen MacKay of RBC Capital, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Buy with Decreased Target from $155 to $125 on, Feb 26th, 2016.

Kennen has made no other calls on BMRN in the last 4 months.



There is 1 other peer that has a rating on BMRN. Out of the 1 peers that are also analyzing BMRN, 0 agree with Kennen's Rating of Hold.



This is the rating of the analyst that currently disagrees with Kennen


  • Joseph Schwartz of "Leerink Swann" Maintained at Buy with Decreased Target to $120 on, Tuesday, February 23rd, 2016